Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches

Fritsch, 1998, Photodynamic therapy in dermatology, Arch Dermatol, 134, 207, 10.1001/archderm.134.2.207

Williams, 2003, Transdermal and Topical Drug Delivery

Uehlinger, 2000, 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells, J Photochem Photobiol B, 54, 72, 10.1016/S1011-1344(99)00159-1

Casas, 2000, The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization, Br J Dermatol, 143, 564, 10.1111/j.1365-2133.2000.03711.x

Malik, 1995, Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice, J Photochem Photobiol B, 28, 213, 10.1016/1011-1344(95)07117-K

Roberts, 1994, Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolevulinic acid, Int J Oncol, 5, 763

Barry, 1987, Mode of action of penetration enhancers in human skin, J Control Release, 6, 85, 10.1016/0168-3659(87)90066-6

Goodman, 1989, Lipid-protein partitioning theory of skin enhancer activity: finite dose technique, Int J Pharm, 57, 29, 10.1016/0378-5173(89)90260-3

Van Den Akker, 2000, Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum, Photochem Photobiol, 72, 681, 10.1562/0031-8655(2000)072<0681:TAOAAH>2.0.CO;2

Steluti, 2005, Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protoporphyrin IX accumulation in hairless mouse skin, Eur J Pharm Biopharm, 60, 439, 10.1016/j.ejpb.2005.01.011

Auner, 2004, Influence of 6-ketocholestanol on skin permeation of 5-aminolevulinic acid and evaluation of chemical stability, J Pharm Sci, 93, 2780, 10.1002/jps.20130

Pierre, 2006, Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy, Pharm Res, 23, 360, 10.1007/s11095-005-9261-x

Fauteck, 2008, Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses, Arch Dermatol Res, 300, 53, 10.1007/s00403-007-0787-0

Lieb, 2002, Self-adhesive thin films for topical delivery of 5-aminolevulinic acid, Eur J Pharm Biopharm, 53, 99, 10.1016/S0939-6411(01)00193-X

McCarron, 2006, Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions, Eur J Pharm Sci, 27, 268, 10.1016/j.ejps.2005.10.009

McCarron, 2005, Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions, Int J Pharm, 293, 11, 10.1016/j.ijpharm.2004.11.035

Bugaj, 2006, The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid, J Photochem Photobiol B, 83, 94, 10.1016/j.jphotobiol.2005.12.003

2004, Labrafac PG data sheet

2004, Labrafil M1944CS data sheet

Novo, 1996, Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours, J Photochem Photobiol B, 34, 143, 10.1016/1011-1344(96)07285-5

Narishetty, 2004, Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action, J Control Release, 95, 367, 10.1016/j.jconrel.2003.11.022

Meyer, 1978, The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig, Curr Probl Dermatol, 7, 39, 10.1159/000401274

Bronaugh, 1982, Methods for in vitro percutaneous absorption studies. II. Animal models for human skin, Toxicol Appl Pharmacol, 62, 481, 10.1016/0041-008X(82)90149-1

Donnelly, 2006, Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues, J Photochem Photobiol B, 82, 59, 10.1016/j.jphotobiol.2005.08.007

Kligman, 1963, Preparation of isolated sheets of human stratum corneum, Arch Dermatol, 88, 702, 10.1001/archderm.1963.01590240026005

Juzeniene, 2002, Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model, Photochem Photobiol, 76, 329, 10.1562/0031-8655(2002)076<0329:TAOAAA>2.0.CO;2

Auner, 2003, Influence of lipophilic counter-ions in combination with phloretin and 6-ketocholestanol on the skin permeation of 5-aminolevulinic acid, Int J Pharm, 255, 109, 10.1016/S0378-5173(03)00053-X

Fang, 2004, Enhancement of topical 5-aminolaevulinic acid delivery by erbium: YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation, Br J Dermatol, 151, 132, 10.1111/j.1365-2133.2004.06051.x

Donnelly, 2007, Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: application to photodynamic tumour targeting, J Photochem Photobiol B, 89, 98, 10.1016/j.jphotobiol.2007.09.009

Donnelly, 2008, Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy, J Control Release, 129, 154, 10.1016/j.jconrel.2008.05.002

Lopez, 2001, Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH, Pharm Res, 18, 311, 10.1023/A:1011050829531

Fujita, 1991, Sequential activation of genes for heme pathway enzymes during erythroid differentiation of mouse Friend virus-transformed erythroleukemia cells, Biochim Biophys Acta, 1090, 311, 10.1016/0167-4781(91)90195-R

De Rosa, 2000, A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy, J Control Release, 65, 359, 10.1016/S0168-3659(99)00213-8

Soler, 1999, Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study, Acta Derm Venereol, 79, 204, 10.1080/000155599750010977

Harth, 1998, Modified topical photodynamic therapy of superficial skin tumours, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia, Dermatol Surg, 24, 723, 10.1111/j.1524-4725.1998.tb04240.x

Van Den Akker, 2002, Systemic component of protoporphyrin IX production in nude mouse skin upon topical application of aminolevulinic acid depends on the application conditions, Photochem Photobiol, 75, 172, 10.1562/0031-8655(2002)075<0172:SCOPIP>2.0.CO;2

Perotti, 2003, Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution, Br J Cancer, 88, 432, 10.1038/sj.bjc.6600665

Casas, 2001, ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization, Br J Cancer, 85, 1794, 10.1054/bjoc.2001.2156

Ziolkowski, 2004, Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture, J Exp Ther Oncol, 4, 121

Nokhodchi, 2003, The enhancement effect of surfactants on the penetration of lorazepam through rat skin, Int J Pharm, 250, 359, 10.1016/S0378-5173(02)00554-9

Nokhodchi, 2007, The effect of terpene concentrations on the skin penetration of diclofenac sodium, Int J Pharm, 335, 97, 10.1016/j.ijpharm.2006.10.041

Grüning, 2008, Physicochemical characterisation of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid, J Pharm Sci, 97, 2311, 10.1002/jps.21157

Gilmore, 2006, In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch, Eur J Pharm Biopharm, 63, 295, 10.1016/j.ejpb.2006.03.002

Zawislak, 2004, Successful photodynamic therapy of vulval Paget's disease using a novel patch-based delivery system containing 5-aminolevulinic acid, BJOG, 111, 1143, 10.1111/j.1471-0528.2004.00254.x

McCarron, 2004, Photodynamic treatment of lichen sclerosus and squamous hyperplasia using sustained topical delivery of aminolevulinic acid from a novel bioadhesive, Br J Dermatol, 151, 105

Bugaj, 2006, The effect of dimethyl sulfoxide, 1-[2-(decylthio-)ethyl-]azacyclopentane-2-one and labrafac on porphyrin formation in mouse skin during topical application of methyl 5-aminolevulinate; a fluorescence and extraction study, Photodiagn Photodyn Ther, 3, 27, 10.1016/S1572-1000(05)00109-2

Moan, 1997, Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid, Int J Cancer, 70, 90, 10.1002/(SICI)1097-0215(19970106)70:1<90::AID-IJC14>3.0.CO;2-H

Berg, 1996, The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells, Br J Cancer, 74, 688, 10.1038/bjc.1996.423

Kennedy, 1996, Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results, J Clin Laser Med Surg, 14, 289, 10.1089/clm.1996.14.289

Dokka, 2005, Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin, J Invest Dermatol, 124, 971, 10.1111/j.0022-202X.2005.23672.x

Agarwal, 2000, The pilosebaceous unit: a pivotal route for topical drug delivery, Methods Find Exp Clin Pharmacol, 22, 129, 10.1358/mf.2000.22.2.796082

Essa, 2002, Human skin sandwich for assessing shunt route penetration during passive and iontophoretic drug and liposome delivery, J Pharm Pharmacol, 54, 1481, 10.1211/002235702135

Trommer, 2006, Overcoming the stratum corneum: the modulation of skin penetration. A review, Skin Pharmacol Physiol, 19, 106, 10.1159/000091978

Williams, 2004, Penetration enhancers, Adv Drug Deliv Rev, 56, 603, 10.1016/j.addr.2003.10.025

Koyama, 1994, Comparative analysis of percutaneous absorption enhancement by d-limonene and oleic acid based on a skin diffusion model, Pharm Res, 11, 377, 10.1023/A:1018904802566